← Evidence map

ReviewClinical epigenetics2021

SMYD3: a regulator of epigenetic and signaling pathways in cancer.

Benjamin J Bernard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

43 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33637115